NOVARTIS FDA Approval ANDA 083149

ANDA 083149

NOVARTIS

FDA Drug Application

Application #083149

Application Sponsors

ANDA 083149NOVARTIS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL25MG0PBZTRIPELENNAMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1973-09-06
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1983-10-12
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1983-10-12
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1983-10-12
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1985-04-16
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1985-04-16
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1995-08-03
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1997-10-30
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1997-03-26
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1997-08-06
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1999-07-20

Submissions Property Types

SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 83149
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.